In consultation: Guidance and quality standards
Showing 1 to 2 of 2
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| Leriglitazone for treating cerebral adrenoleukodystrophy in boys and men 2 years and over [ID3903] | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| Lutetium-177 vipivotide tetraxetan in combination for treating PSMA-positive hormone-sensitive metastatic prostate cancer [ID6589] | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance |